These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17227834)

  • 1. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.
    Gruber A; Marzec UM; Bush L; Di Cera E; Fernández JA; Berny MA; Tucker EI; McCarty OJ; Griffin JH; Hanson SR
    Blood; 2007 May; 109(9):3733-40. PubMed ID: 17227834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.
    Gruber A; Fernández JA; Bush L; Marzec U; Griffin JH; Hanson SR; DI Cera E
    J Thromb Haemost; 2006 Feb; 4(2):392-7. PubMed ID: 16420571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.
    Gruber A; Hanson SR; Kelly AB; Yan BS; Bang N; Griffin JH; Harker LA
    Circulation; 1990 Aug; 82(2):578-85. PubMed ID: 2372904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y; Harker LA; Hanson SR
    J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
    Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
    Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
    Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
    Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.
    Gruber A; Carlsson S; Kotzé HF; Marzec U; Sarich TC; Hanson SR
    Thromb Res; 2007; 119(1):121-7. PubMed ID: 16448687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of thrombin into an anticoagulant by protein engineering.
    Gibbs CS; Coutré SE; Tsiang M; Li WX; Jain AK; Dunn KE; Law VS; Mao CT; Matsumura SY; Mejza SJ
    Nature; 1995 Nov; 378(6555):413-6. PubMed ID: 7477382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
    Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
    Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
    Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
    Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein C system and thrombosis diseases].
    Taran LD
    Ukr Biokhim Zh (1999); 2003; 75(1):18-24. PubMed ID: 14574731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic efficacy in the guinea pig of a derivative of human protein C with enhanced activation by thrombin.
    Kurz KD; Smith T; Wilson A; Gerlitz B; Richardson MA; Grinnell BW
    Blood; 1997 Jan; 89(2):534-40. PubMed ID: 9002956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.
    Schaffer LW; Davidson JT; Vlasuk GP; Dunwiddie CT; Siegl PK
    Arterioscler Thromb; 1992 Aug; 12(8):879-85. PubMed ID: 1637785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.
    Heeb MJ; Marzec U; Gruber A; Hanson SR
    Thromb Haemost; 2012 Apr; 107(4):690-8. PubMed ID: 22370911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
    Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
    Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
    Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.